• News

    HDA Names Hannah Seitzinger Director of State Government Affairs

    September 02, 2025

    The Healthcare Distribution Alliance (HDA) announces the addition of Hannah Seitzinger as Director, State Government Affairs. In this role, Ms. Seitzinger will represent HDA’s healthcare distributor members in multiple states across the Midwest and report to Leah Lindahl, Vice President, State Government Affairs.

  • News

    HDA Statement on DSCSA Implementation Milestone For Distributors

    August 27, 2025

    The Healthcare Distribution Alliance (HDA) released a statement from President and CEO Chester “Chip” Davis, Jr., at the close of the Food and Drug Administration’s (FDA) Drug Supply Chain Security Act (DSCSA) exemption period for distributors.

  • News

    HDA Honors Rx and Consumer Product Manufacturers With DIANA Awards

    June 03, 2025

    The Healthcare Distribution Alliance (HDA) honored 10 pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2025 HDA Business and Leadership Conference in Orlando, Fla.

  • News

    HDA Research Foundation Recognizes Craig Cowman of Cardinal Health With Nexus Award

    June 03, 2025

    The HDA Research Foundation honored Craig Cowman, Executive Vice President of Biopharma Solutions and Strategic Sourcing for Cardinal Health, Inc., with the 2025 Nexus Award for Lifetime Achievement. The award was presented last night at the Healthcare Distribution Alliance’s (HDA) Business and Leadership Conference in Orlando.

  • News

    Americares Honors Teva with Power of Partnership Award

    June 02, 2025

    Americares, in partnership with the Healthcare Distribution Alliance (HDA), presented its annual Power of Partnership Award to Teva Pharmaceuticals, a biopharmaceutical company, in recognition of its outstanding commitment to increasing access to medicines for patients in need worldwide.

  • News

    HDA Statement on “Most-Favored-Nation” Executive Order

    May 12, 2025

    HDA released a statement in response to President Donald J. Trump’s Executive Order establishing a “Most-Favored-Nation” (MFN) pricing policy for pharmaceuticals.

Media Contacts

John Parker
Chief Communications Officer

Farah Simonett
Vice President, Communications and Marketing

Elizabeth Baker
Director, Communications